 |
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, May 22, 2013
|
|
|
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, May 22, 2013
|
| Home | HealthTopics | Health Centers | Reference Library | Research |
 Join us on Facebook
|
Share on Facebook | Tweet |
|
Skin Care and Diseases |
Rosacea02/16/2006 |
I have Rosacea, mostly affecting the nose. I recently started Tazorac to unblock deeply clogged pores. I know it can cause redness at first, but since I started the Tazorac two weeks ago, it makes the red blotchy spots worse. Is this temporary or will this likely be a permanent side effect?
It is common to have an increased inflammatory response on facial skin following the use of topical retinoids. Tazorac is a very powerful drug and will certainly improve your rosacea in the long run. You may wish to talk to your dermatologist about the use of other anti-inflammary agents to minimize the blotchiness of your nose. This is likely a temporary process and usually subsides as treatment progresses. It may, however, take several months. Talk to your physician. I am sure he/she is aware of all of the problems associated with Tazorac use.
|
Charles L Heaton, MD Professor College of Medicine University of Cincinnati |
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|